| NEWSLETTER |
Cliquer ici pour s'abonner à
notre newsletter. |
|
| NEWS | |
|
11/03/2010
- Cellvizio apporte de l'espoir en Alabama
Shyam Varadarajulu, de l'Université d'Alabama, explique dans le Birmingham Medical News en quoi Cellvizio améliore le diagnostic, le traitement des patients et permet de réduire le coût et la durée des procédures.
|
|
Cellvizio® Mouse Atlas with VisEn Medical Fluorescent Probes
Understanding biological processes: the power of molecular imaging by combined use of state-of-the-art technologies. (All images acquired on living animals!)
|
|
Vasculature of the kidney of a mouse after IV injection of AngioSense®680.
Images acquired with the Cellvizio®635. ProFlex: MiniO. Fov: 240 x 200 µm.
Courtesy of Raphaël Boisgard and Bertrand Tavitian, CEA-SHFJ, U803, Orsay, France.
|
|
Vasculature of the bladder of a mouse after IV injection of AngioSense®680.
Images acquired with the Cellvizio®635. ProFlex: prototype Z-Proflex. Fov: 400x280 µm.
Courtesy of Raphaël Boisgard and Bertrand Tavitian, CEA-SHFJ, U803, Orsay, France.
|
|
Vasculature of the intestine of a mouse after IV injection of AngioSense®680.
Images acquired with the Cellvizio®635. ProFlex: S-1500. Fov: 400x280 µm.
Courtesy of Raphaël Boisgard and Bertrand Tavitian, CEA-SHFJ, U803, Orsay, France.
|
|
Vascularization of a sub-cutanous tumor after IV injection of AngioSense®680.
Images acquired with the Cellvizio®635. ProFlex: MiniO. Fov: 240 µm.
Courtesy of Raphaël Boisgard and Bertrand Tavitian, CEA-SHFJ, U803, Orsay, France.
|
|
Vasculature of the liver of a mouse after IV injection of AngioSense®680.
Images acquired with the Cellvizio®635. ProFlex: MiniO. Fov: 240 µm.
Courtesy of Raphaël Boisgard and Bertrand Tavitian, CEA-SHFJ, U803, Orsay, France.
|
|
Vasculature of a tumor xenograft model after IV injection of AngioSense®680.
Images acquired with the Cellvizio®660. ProFlex: S-1500. Fov: 400 x 280 µm.
Courtesy of VisEn Medical
|
|
Visualization of colon vasculature with AngioSPARK™680.
Images acquire with the Cellvizio®660. ProFlex: S-1500. Fov: 400 x 280 µm.
Courtesy of Marco Maricevich, Center for Molecular Imaging Research, Massachusetts General Hospital, Boston, USA.
|
|
Vascularization of mouse cecum wall after IV injection of AngioSense®680.
Images acquired with the Cellvizio®660 and reconstructed with a mosaicing software plug-in. ProFlex: S-1500. Fov: 1.3 mm.
Courtesy of Marco Maricevich, Center for Molecular Imaging Research, Massachusetts General Hospital, Boston, USA.
|
|
Normal pancreas (upper dark image) and orthotopically implanted pancreatic cancer cells (lower image) imaged with ProSense®680. This couple of images illustrates the very good specificity of the combined use of the smart probe ProSense™ and the Cellvizio® for detection of tumoral activity.
Images acquired with the Cellvizio® 660. ProFlex: MiniO. Fov: 160 x 120 µm.
Courtesy of Dieter Saur, Johannes von Burstin, II. Medizinische Klinik, Technical University of Munich, Munich, Germany.
|
|
Mouse subcutanous tumor after IV injection of ProSense®680
Image acquired with the Cellvizio®660.
ProFlex: MiniO. Fov: 240 µm.
Courtesy of Frédéric Ducongé and Bertrand Tavitian, CEA-SHFJ, U803, Orsay, France
|
|
Mouse spleen after IV injection of ProSense®680
Image acquired with the Cellvizio®660.
ProFlex: MiniO. Fov: 240 µm.
Courtesy of Frédéric Ducongé and Bertrand Tavitian, CEA-SHFJ, U803, Orsay, France
|
|
|
CALENDAR |
|
|
20/03/2010
- ICCU 2010
Un lieu unique pour un évènement unique: la 2ème Conférence Internationale des Utilisateurs Cellvizio se déroulera à Paris du 20 au 22 mars 2010
|
|
02/05/2010
- DDW 2010
Come discover the latest Cellvizio developments at DDW 2010 in New Orleans. Visit us at booth #547 for a hands-on experience of Cellvizio.
|
|
